StockTipsArenaBeta

BUY Sun Pharmaceutical Industries Ltd. — HDFC Securities

BUYSun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries share price target & all analyst calls

byHDFC SecuritiesHorizon: NA (inferred 1–3 months)13 Jul 2026via Economic Times New Stock Recos

Entry₹1,933.65Inferred
Target₹2,120
Total upside +9.64% (call closed)
Stop lossNot given
At expiry₹1,770.713 Oct 2026, 3:30 pm
Expired-8.43%auction close
Follow HDFC Securities for new callsGet alertsWatch SUNPHARMA for new buy/sell callsGet alertsSee 3 active Short-term calls on SUNPHARMASee 44 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 13 Oct 2026
13 supporting4 neutral4 opposing
Supports the BUY call (13)

13 advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·7 Oct · 6d ago

Sun Pharma to acquire Innovcare Lifesciences for ₹271.2 crore

NewsGoogle News·4 Oct · 1w ago

(opens in new tab)

Sun Pharmaceutical has entered into a licensing agreement for lerodalcibep, a novel drug candidate, expanding its specialty portfolio.

BSE · Company Update·28 Sept · 2w ago

(opens in new tab)

Sun Pharma to acquire Innovcare Lifesciences for ₹271.2 crore

NewsGoogle News·20 Sept · 3w ago

(opens in new tab)

3 other SEBI-registered advisors have active short-term BUY calls on this stock

Advisor consensus · same horizon·30 Jul · 2mo ago

Neutral / worth noting (4)

Sun Pharma to consider ₹15,000 crore NCD issue; board meeting on 12 October

NewsLivemint·7 Oct · 5d ago

(opens in new tab)
Weighs against the BUY call (4)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sun Pharmaceutical Industries

All analyst calls on Sun Pharmaceutical Industries

More from HDFC Securities

Every call and its outcome